Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2007; 13(6): 950-954
Published online Feb 14, 2007. doi: 10.3748/wjg.v13.i6.950
Published online Feb 14, 2007. doi: 10.3748/wjg.v13.i6.950
Table 1 Characteristics of patients
| Characteristics | Colorectal cancern = 52 | Benign controln = 35 | Normal controln = 24 |
| Sex | |||
| Male | 31 | 20 | 13 |
| Female | 21 | 15 | 11 |
| Age | |||
| Mean ± SD | 63.5 ± 11.8 | 60.0 ± 10.3 | 59.6 ± 8.2 |
| Range | 25-81 | 31-79 | 35-68 |
| Dukes stage | |||
| A + B | 27 | Na | Na |
| C + D | 25 | Na | Na |
| Nodal status | |||
| Positive | 23 | Na | Na |
| Negative | 29 | Na | Na |
| Tumor size | |||
| > 5 cm | 19 | Na | Na |
| ≤ 5 cm | 33 | Na | Na |
| Tumor locus | |||
| Rectum | 24 | Na | Na |
| Distal colon | 16 | Na | Na |
| Proximal colon | 12 | Na | Na |
- Citation: Huang ZH, Li LH, Yang F, Wang JF. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol 2007; 13(6): 950-954
- URL: https://www.wjgnet.com/1007-9327/full/v13/i6/950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i6.950